I think it’s a combination of lack of awareness

I think it’s a combination of lack of awareness and dilution. I was also super frustrated when the Ph2 data didn’t give us a bump and it’s so irritating to see big Pharma just roll over us with seemingly inferior products and get endorsed by the US govt. We are over 1.1 billion shares now, which is fine if things continue moving forward as planned, but I’m sure it scares some new investors who want to see more data before diving in. I also think Tollovid won’t move the SP the way a potential prescription drug could, ie tollovir, without numbers behind it. Hopefully, when we see numbers in a few days, they will tell the story Gerald has been telling on twitter and we will see a move in the right direction. Either way, patience should reward us. In the meantime, buy at these levels if you have the funds (unfortunately I’m all out for now).